Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022; 21: 99-104
Циторедукция и гипертермическая химиоперфузия плевральной полости у ребенка с десмопластической мелкокруглоклеточной опухолью. Первый отечественный опыт
https://doi.org/10.24287/1726-1708-2022-21-4-99-104Аннотация
Десмопластическая мелкокруглоклеточная опухоль – редкое агрессивное злокачественное новообразование. Наиболее часто локализуется в брюшной полости, в исключительных случаях поражает органы грудной клетки. В статье представлено клиническое наблюдение пациента 10 лет с десмопластической мелкокруглоклеточной опухолью плевральной полости. В качестве локального контроля пациенту впервые в отечественной практике проведена гипертермическая внутриплевральная химиоперфузия, которая описана в данной статье. Родители пациента дали согласие на использование информации, в том числе фотографий ребенка, в научных исследованиях и публикациях.
Список литературы
1. Tsuyoshi H., Inoue D., Kurokawa T., Yoshida Y. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res 2020; 46: 1661–71. DOI:10.1111/jog.14391
2. Klempner S.J., Ryan D.P. HIPEC for colorectal peritoneal metastases. Lancet Oncol 2021; 22 (2): 162–4. DOI:10.1016/S1470-2045(20)30693-8
3. Liu L., Zhang N., Min J., Su H., Wang H., Chen D., et al. Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC). Oncotarget 2016; 7: 21570–8. DOI:10.18632/oncotarget.7622
4. Yellin A., Simansky D.A., Paley M., Refaely Y. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer 2001; 92: 2197–203. DOI:10.1002/1097-0142(20011015)92:8<2197::aid-cncr1563>3.0.co;2-f
5. Zhou H., Wu W., Tang X., Zhou J., Shen Y. Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis. Medicine 2017; 96: e5532. DOI:10.1097/MD.0000000000005532
6. Honoré C., Atallah V., Mir O., Orbach D., Ferron G., LePéchoux C., et al. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? PLoS One 2017; 12: e0171639. DOI:10.1371/journal.pone.0171639
7. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 Suppl: S15–25. DOI:10.1007/s002800051093
8. Jayakrishnan T., Moll R., Sandhu A., Sanguino A., Kaur G., Mao S. Desmoplastic Small Round-cell Tumor: Retrospective Review of Institutional Data and Literature Review. Anticancer Res 2021; 41: 3859–66. DOI:10.21873/anticanres.15179
9. Raizada N., Daga M.K., Sinha N., Kumar R., Nayak H., Kamble N.L., et al. A rapidly developing lung mass diagnosed as desmoplastic small round cell tumor. Lung India 2011; 28: 287–90. DOI:10.4103/0970-2113.85692
10. Hayes-Jordan A., LaQuaglia M.P., Modak S. Management of desmoplastic small round cell tumor. Semin Pediatr Surg 2016; 25: 299–304. DOI:10.1053/j.sempedsurg.2016.09.005
11. Dufresne A., Cassier P., Couraud L., Marec-Bérard P., Meeus P., Alberti L., et al. Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings. Sarcoma 2012; 2012: 714986. DOI:10.1155/2012/714986
12. Hayes-Jordan A., Green H., Fitzgerald N., Xiao L., Anderson P. Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg 2010; 45 (5): 1000–6. DOI:10.1016/j.jpedsurg.2010.02.034
13. Jin D., Chen M., Wang B., Gou Y. Mediastinal desmoplastic small round cell tumor. Medicine 2020; 99: e22921. DOI:10.1097/MD.0000000000022921
14. Jellouli M., Mekki M., Krichene I., Zakhama A., Belghith M., Jouini R., et al. Intra-abdominal desmoplastic small round cell tumor in childhood: case report and review of the literature. Bull Cancer 2003; 90: 1063–6.
15. Петрикова Н.И., Ефременков A.M., Сниткин Н.A., Трунова Р.Б., Бурлуцкая T.И. Десмопластическая мелкокруглоклеточная опухоль у ребенка. Онкопедиатрия 2016; 3: 42–7. DOI:10.15690/onco.v3i1.1528
16. Kushner B.H., LaQuaglia M.P., Wollner N., Meyers P.A., Lindsley K.L., Ghavimi F., et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996; 14 (5): 1526–31. DOI:10.1200/jco.1996.14.5.1526
17. Fois A.G., Pirina P., Arcadu A., Becciu F., Manca S., Marras V., et al. Desmoplastic small round cell tumors of the pleura: a review of the clinical literature. Multidiscip Respir Med 2017; 12: 22. DOI:10.1186/s40248-017-0103-6
18. Spratt J.S., Adcock R.A., Sherrill W., Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res 1980; 40: 253–5.
19. Baronzio G., Schwartz L., Kiselevsky M., Guais A., Sanders E., Milanesi G., et al. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis. Anticancer Res 2012; 32: 405–14.
20. Ахаладзе Д.Г., Рабаев Г.С., Грачев Н.С. Циторедуктивные операции и внутрибрюшная гипертермическая химиоперфузия у детей. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019; 18 (4): 118‒26. DOI:10.24287/1726-1708-2019-18-4-118-126
21. Howell S.B., Pfeifle C.L., Wung W.E., Olshen R.A., Lucas W.E., Yon J.L., et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845–51. DOI:10.7326/0003-4819-97-6-845
22. Himmelstein K.J., Patton T.F., Belt R.J., Taylor S., Repta A.J., Sternson L.A. Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther 1981; 29: 658–64. DOI:10.1038/clpt.1981.91
23. Ried M., Eichhorn M., Winter H., Grützner U., Lindner M., Hatz R.A., et al. Expert Recommendation for the Implementation of Hyperthermic Intrathoracic Chemotherapy (HITOC) in Germany. Zentralbl Chir 2020; 145: 89–98. DOI:10.1055/a-0934-7806
24. Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004; 240: 278–85. DOI:10.1097/01.sla.0000133183.15705.71
25. Dayal S., Taflampas P., Riss S., Chandrakumaran K., Cecil T.D., Mohamed F., et al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 2013; 56: 1366–72. DOI:10.1097/DCR.0b013e3182a62b0d
26. [Internet] PROMISE – Welcome to PROMISE evaluation. URL: https://www.e-promise.org. (Date of access to the source 10.11.2022).
27. Ахаладзе Д.Г., Рабаев Г.С., Грачев Н.С. Технические особенности циторедуктивных операций и внутрибрюшной гипертермической химиоперфузии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2020; 19 (4): 224–33. doi:10.24287/1726-1708-2020-19-4-224-233
28. Da Silva R.G., Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203: 878–86. DOI:10.1016/j.jamcollsurg.2006.08.024
Pediatric Hematology/Oncology and Immunopathology. 2022; 21: 99-104
Cytoreductive surgery and hyperthermic chemoperfusion of the pleural cavity in a child with desmoplastic small round cell tumor. The first Russian experience
https://doi.org/10.24287/1726-1708-2022-21-4-99-104Abstract
Desmoplastic small round cell tumor is a rare and aggressive malignant tumor. The abdominal cavity is the most frequent site of this tumor, but rarely it affects the pleural cavity. This article presents a clinical case of a 10-year-old male with a desmoplastic small round cell tumor of the pleural cavity. Here we describe the first experience of hyperthermic intrapleural chemoperfusion in a pediatric patient in Russia. The patients' parents gave their consent to the use of their children's data, including photographs, for research purposes and in publications.
References
1. Tsuyoshi H., Inoue D., Kurokawa T., Yoshida Y. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res 2020; 46: 1661–71. DOI:10.1111/jog.14391
2. Klempner S.J., Ryan D.P. HIPEC for colorectal peritoneal metastases. Lancet Oncol 2021; 22 (2): 162–4. DOI:10.1016/S1470-2045(20)30693-8
3. Liu L., Zhang N., Min J., Su H., Wang H., Chen D., et al. Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC). Oncotarget 2016; 7: 21570–8. DOI:10.18632/oncotarget.7622
4. Yellin A., Simansky D.A., Paley M., Refaely Y. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer 2001; 92: 2197–203. DOI:10.1002/1097-0142(20011015)92:8<2197::aid-cncr1563>3.0.co;2-f
5. Zhou H., Wu W., Tang X., Zhou J., Shen Y. Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis. Medicine 2017; 96: e5532. DOI:10.1097/MD.0000000000005532
6. Honoré C., Atallah V., Mir O., Orbach D., Ferron G., LePéchoux C., et al. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? PLoS One 2017; 12: e0171639. DOI:10.1371/journal.pone.0171639
7. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 Suppl: S15–25. DOI:10.1007/s002800051093
8. Jayakrishnan T., Moll R., Sandhu A., Sanguino A., Kaur G., Mao S. Desmoplastic Small Round-cell Tumor: Retrospective Review of Institutional Data and Literature Review. Anticancer Res 2021; 41: 3859–66. DOI:10.21873/anticanres.15179
9. Raizada N., Daga M.K., Sinha N., Kumar R., Nayak H., Kamble N.L., et al. A rapidly developing lung mass diagnosed as desmoplastic small round cell tumor. Lung India 2011; 28: 287–90. DOI:10.4103/0970-2113.85692
10. Hayes-Jordan A., LaQuaglia M.P., Modak S. Management of desmoplastic small round cell tumor. Semin Pediatr Surg 2016; 25: 299–304. DOI:10.1053/j.sempedsurg.2016.09.005
11. Dufresne A., Cassier P., Couraud L., Marec-Bérard P., Meeus P., Alberti L., et al. Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings. Sarcoma 2012; 2012: 714986. DOI:10.1155/2012/714986
12. Hayes-Jordan A., Green H., Fitzgerald N., Xiao L., Anderson P. Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion. J Pediatr Surg 2010; 45 (5): 1000–6. DOI:10.1016/j.jpedsurg.2010.02.034
13. Jin D., Chen M., Wang B., Gou Y. Mediastinal desmoplastic small round cell tumor. Medicine 2020; 99: e22921. DOI:10.1097/MD.0000000000022921
14. Jellouli M., Mekki M., Krichene I., Zakhama A., Belghith M., Jouini R., et al. Intra-abdominal desmoplastic small round cell tumor in childhood: case report and review of the literature. Bull Cancer 2003; 90: 1063–6.
15. Petrikova N.I., Efremenkov A.M., Snitkin N.A., Trunova R.B., Burlutskaya T.I. Desmoplasticheskaya melkokruglokletochnaya opukhol' u rebenka. Onkopediatriya 2016; 3: 42–7. DOI:10.15690/onco.v3i1.1528
16. Kushner B.H., LaQuaglia M.P., Wollner N., Meyers P.A., Lindsley K.L., Ghavimi F., et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996; 14 (5): 1526–31. DOI:10.1200/jco.1996.14.5.1526
17. Fois A.G., Pirina P., Arcadu A., Becciu F., Manca S., Marras V., et al. Desmoplastic small round cell tumors of the pleura: a review of the clinical literature. Multidiscip Respir Med 2017; 12: 22. DOI:10.1186/s40248-017-0103-6
18. Spratt J.S., Adcock R.A., Sherrill W., Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res 1980; 40: 253–5.
19. Baronzio G., Schwartz L., Kiselevsky M., Guais A., Sanders E., Milanesi G., et al. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis. Anticancer Res 2012; 32: 405–14.
20. Akhaladze D.G., Rabaev G.S., Grachev N.S. Tsitoreduktivnye operatsii i vnutribryushnaya gipertermicheskaya khimioperfuziya u detei. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2019; 18 (4): 118‒26. DOI:10.24287/1726-1708-2019-18-4-118-126
21. Howell S.B., Pfeifle C.L., Wung W.E., Olshen R.A., Lucas W.E., Yon J.L., et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845–51. DOI:10.7326/0003-4819-97-6-845
22. Himmelstein K.J., Patton T.F., Belt R.J., Taylor S., Repta A.J., Sternson L.A. Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther 1981; 29: 658–64. DOI:10.1038/clpt.1981.91
23. Ried M., Eichhorn M., Winter H., Grützner U., Lindner M., Hatz R.A., et al. Expert Recommendation for the Implementation of Hyperthermic Intrathoracic Chemotherapy (HITOC) in Germany. Zentralbl Chir 2020; 145: 89–98. DOI:10.1055/a-0934-7806
24. Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004; 240: 278–85. DOI:10.1097/01.sla.0000133183.15705.71
25. Dayal S., Taflampas P., Riss S., Chandrakumaran K., Cecil T.D., Mohamed F., et al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 2013; 56: 1366–72. DOI:10.1097/DCR.0b013e3182a62b0d
26. [Internet] PROMISE – Welcome to PROMISE evaluation. URL: https://www.e-promise.org. (Date of access to the source 10.11.2022).
27. Akhaladze D.G., Rabaev G.S., Grachev N.S. Tekhnicheskie osobennosti tsitoreduktivnykh operatsii i vnutribryushnoi gipertermicheskoi khimioperfuzii. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2020; 19 (4): 224–33. doi:10.24287/1726-1708-2020-19-4-224-233
28. Da Silva R.G., Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203: 878–86. DOI:10.1016/j.jamcollsurg.2006.08.024
